Actinium reports ATNM-400 cancer therapy data at AACR meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Actinium Pharmaceuticals, Inc. (NYSE: ATNM) | Delayed: 1.10 +0.02 (1.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.08 | 52 Week High | $3.50 | |||
| Open | $1.09 | 52 Week Low | $0.86 | |||
| Day High | $1.12 | P/E | N/A | |||
| Day Low | $1.07 | EPS | $-7.61 | |||
| Volume | 105,763 | |||||
